AHR and systemic lupus erythematosus: To investigate whether the AhR agonist tapinarof could ameliorate SLE clinical features, 14‐week‐old MRL/lpr mice were intraperitoneally administered different concentrations of tapinarof or vehicle every other day for 6 weeks (Figure 1A).